New mutational profile in HIV-1 Gag cleavage site correlated with phenotypic drug resistance

Details for Australian Patent Application No. 2008257703 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Dierynck, Inge; De Meyer, Sandra

Agent Shelston IP

Pub. Number AU-A-2008257703

PCT Pub. Number WO2008/145606

Priority 07108899.1 25.05.07 EP

Filing date 23 May 2008

Wipo publication date 4 December 2008

International Classifications

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/145606 Priority application(s): WO2008/145606

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the name of applicant from Tibotec Pharmaceuticals Ltd. to Tibotec Pharmaceuticals

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008257712-Control system

2008257695-Enhanced delivery of certain fragrance components from personal care compositions